
Therapeutic potential of garlic, aged garlic extract and garlic‑derived compounds on pancreatic cancer (Review)
- Authors:
- Hiromichi Kawasaki
- Gabriel Nussbaum
-
Affiliations: Institute of Biomedical and Oral Research, Hebrew University of Jerusalem, Jerusalem 9112102, Israel - Published online on: January 27, 2025 https://doi.org/10.3892/br.2025.1932
- Article Number: 54
-
Copyright: © Kawasaki et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
![]() |
De Greef D, Barton EM, Sandberg EN, Croley CR, Pumarol J, Wong TL, Das N and Bishayee A: Anticancer potential of garlic and its bioactive constituents: A systematic and comprehensive review. Semin Cancer Biol. 73:219–264. 2021.PubMed/NCBI View Article : Google Scholar | |
Ryu K, Ide N, Matsuura H and Itakura Y: N alpha-(1-deoxy-D-fructos-1-yl)-L-arginine, an antioxidant compound identified in aged garlic extract. J Nutr. 131:972S–976S. 2001.PubMed/NCBI View Article : Google Scholar | |
Matsutomo T: Potential benefits of garlic and other dietary supplements for the management of hypertension. Exp Ther Med. 19:1479–1484. 2020.PubMed/NCBI View Article : Google Scholar | |
Ohtani M and Nishimura T: The preventive and therapeutic application of garlic and other plant ingredients in the treatment of periodontal diseases. Exp Ther Med. 19:1507–1510. 2020.PubMed/NCBI View Article : Google Scholar | |
Tanaka S, Haruma K, Yoshihara M, Kajiyama G, Kira K, Amagase H and Chayama K: Aged garlic extract has potential suppressive effect on colorectal adenomas in humans. J Nutr. 136 (Suppl 3):821S–826S. 2006.PubMed/NCBI View Article : Google Scholar | |
Jikihara H, Qi G, Nozoe K, Hirokawa M, Sato H, Sugihara Y and Shimamoto F: Aged garlic extract inhibits 1,2-dimethylhydrazine-induced colon tumor development by suppressing cell proliferation. Oncol Rep. 33:1131–1140. 2015.PubMed/NCBI View Article : Google Scholar | |
Ohkubo S, Dalla Via L, Grancara S, Kanamori Y, García-Argáez AN, Canettieri G, Arcari P, Toninello A and Agostinelli E: The antioxidant, aged garlic extract, exerts cytotoxic effects on wild-type and multidrug-resistant human cancer cells by altering mitochondrial permeability. Int J Oncol. 53:1257–1268. 2018.PubMed/NCBI View Article : Google Scholar | |
Ishikawa H, Saeki T, Otani T, Suzuki T, Shimozuma K, Nishino H, Fukuda S and Morimoto K: Aged garlic extract prevents a decline of NK cell number and activity in patients with advanced cancer. J Nutr. 136 (Suppl 3):816S–820S. 2006.PubMed/NCBI View Article : Google Scholar | |
Li WQ, Zhang JY, Ma JL, Li ZX, Zhang L, Zhang Y, Guo Y, Zhou T, Li JY, Shen L, et al: Effects of Helicobacter pylori treatment and vitamin and garlic supplementation on gastric cancer incidence and mortality: Follow-up of a randomized intervention trial. BMJ. 366(l5016)2019.PubMed/NCBI View Article : Google Scholar | |
Rawla P, Sunkara T and Gaduputi V: Epidemiology of pancreatic cancer: Global trends, etiology and risk factors. World J Oncol. 10:10–27. 2019.PubMed/NCBI View Article : Google Scholar | |
Michaud DS: Role of bacterial infections in pancreatic cancer. Carcinogenesis. 34:2193–2197. 2013.PubMed/NCBI View Article : Google Scholar | |
Thomas RM and Jobin C: Microbiota in pancreatic health and disease: The next frontier in microbiome research. Nat Rev Gastroenterol Hepatol. 17:53–64. 2020.PubMed/NCBI View Article : Google Scholar | |
Abe S, Masuda A, Matsumoto T, Inoue J, Toyama H, Sakai A, Kobayashi T, Tanaka T, Tsujimae M, Yamakawa K, et al: Impact of intratumoral microbiome on tumor immunity and prognosis in human pancreatic ductal adenocarcinoma. J Gastroenterol. 59:250–262. 2024.PubMed/NCBI View Article : Google Scholar | |
Tan Q, Ma X, Yang B, Liu Y, Xie Y, Wang X, Yuan W and Ma J: Periodontitis pathogen Porphyromonas gingivalis promotes pancreatic tumorigenesis via neutrophil elastase from tumor-associated neutrophils. Gut Microbes. 14(2073785)2022.PubMed/NCBI View Article : Google Scholar | |
Saba E, Farhat M, Daoud A, Khashan A, Forkush E, Menahem NH, Makkawi H, Pandi P, Angabo S, Kawasaki H, et al: Oral bacteria accelerate pancreatic cancer development in mice. Gut. 73:770–786. 2024.PubMed/NCBI View Article : Google Scholar | |
Udayasuryan B, Ahmad RN, Nguyen TTD, Umaña A, Roberts LDM, Sobol P, Jones SD, Munson JM, Slade DJ and Verbridge SS: Fusobacterium nucleatum induces proliferation and migration in pancreatic cancer cells through host autocrine and paracrine signaling. Sci Signal. 15(eabn4948)2022.PubMed/NCBI View Article : Google Scholar | |
Hayashi M, Ikenaga N, Nakata K, Luo H, Zhong PS, Date S, Oyama K, Higashijima N, Kubo A, Iwamoto C, et al: Intratumor Fusobacterium nucleatum promotes the progression of pancreatic cancer via the CXCL1-CXCR2 axis. Cancer Sci. 114:3666–3678. 2023.PubMed/NCBI View Article : Google Scholar | |
Zini A, Mann J, Mazor S and Vered Y: Beneficial effect of aged garlic extract on periodontitis: A randomized controlled double-blind clinical study. J Clin Biochem Nutr. 67:297–301. 2020.PubMed/NCBI View Article : Google Scholar | |
Chan JM, Wang F and Holly EA: Vegetable and fruit intake and pancreatic cancer in a population-based case-control study in the San Francisco bay area. Cancer Epidemiol Biomarkers Prev. 14:2093–2097. 2005.PubMed/NCBI View Article : Google Scholar | |
Abe K, Hori Y and Myoda T: Volatile compounds of fresh and processed garlic. Exp Ther Med. 19:1585–1593. 2020.PubMed/NCBI View Article : Google Scholar | |
Trio PZ, You S, He X, He J, Sakao K and Hou DX: Chemopreventive functions and molecular mechanisms of garlic organosulfur compounds. Food Funct. 5:833–844. 2014.PubMed/NCBI View Article : Google Scholar | |
Singh P, Patel M, Bhowmik D, Kumari N, Prajapati SK and Gupta R: Identification of common biomarkers affecting patient survival in cancers. World Acad Sci J. 6(53)2024. | |
Lu L, Gao Z, Song J, Jin L and Liang Z: The potential of diallyl trisulfide for cancer prevention and treatment, with mechanism insights. Front Cell Dev Biol. 12(1450836)2024.PubMed/NCBI View Article : Google Scholar | |
Sarhadi VK and Armengol G: Molecular biomarkers in cancer. Biomolecules. 12(1021)2022.PubMed/NCBI View Article : Google Scholar | |
Sugiura R, Satoh R and Takasaki T: ERK: A double-edged sword in cancer. ERK-dependent apoptosis as a potential therapeutic strategy for cancer. Cells. 10(2509)2021.PubMed/NCBI View Article : Google Scholar | |
Lan XY, Sun HY, Liu JJ, Lin Y, Zhu ZY, Han X, Sun X, Li XR, Zhang HC and Tang ZY: Effects of garlic oil on pancreatic cancer cells. Asian Pac J Cancer Prev. 14:5905–5910. 2013.PubMed/NCBI View Article : Google Scholar | |
Chhabria SV, Akbarsha MA, Li AP, Kharkar PS and Desai KB: In situ allicin generation using targeted alliinase delivery for inhibition of MIA PaCa-2 cells via epigenetic changes, oxidative stress and cyclin-dependent kinase inhibitor (CDKI) expression. Apoptosis. 20:1388–1409. 2015.PubMed/NCBI View Article : Google Scholar | |
Wang CJ, Wang C, Han J, Wang YK, Tang L, Shen DW, Zhao Y, Xu RH and Zhang H: Effect of combined treatment with recombinant interleukin-2 and allicin on pancreatic cancer. Mol Biol Rep. 40:6579–6585. 2013.PubMed/NCBI View Article : Google Scholar | |
Saini V, Manral A, Arora R, Meena P, Gusain S, Saluja D and Tiwari M: Novel synthetic analogs of diallyl disulfide triggers cell cycle arrest and apoptosis via ROS generation in MIA PaCa-2 cells. Pharmacol Rep. 69:813–821. 2017.PubMed/NCBI View Article : Google Scholar | |
Ma HB, Huang S, Yin XR, Zhang Y and Di ZL: Apoptotic pathway induced by diallyl trisulfide in pancreatic cancer cells. World J Gastroenterol. 20:193–203. 2014.PubMed/NCBI View Article : Google Scholar | |
Lee HJ, Jeong JH and Ryu JH: Anti-pancreatic cancer activity of Z-ajoene from garlic: An inhibitor of the Hedgehog/Gli/FoxM1 axis. J Funct Foods. 56:102–109. 2019. | |
Wang W, Cheng J and Zhu Y: The JNK signaling pathway is a novel molecular target for S-propargyl-L-cysteine, a naturally-occurring garlic derivatives: Link to its anticancer activity in pancreatic cancer in vitro and in vivo. Curr Cancer Drug Targets. 15:613–623. 2015.PubMed/NCBI View Article : Google Scholar | |
Murtaugh LC and Keefe MD: Regeneration and repair of the exocrine pancreas. Annu Rev Physiol. 77:229–249. 2015.PubMed/NCBI View Article : Google Scholar | |
Sidhapuriwala JN, Hegde A, Ang AD, Zhu YZ and Bhatia M: Effects of S-propargyl-cysteine (SPRC) in caerulein-induced acute pancreatitis in mice. PLoS One. 7(e32574)2012.PubMed/NCBI View Article : Google Scholar | |
Mathan Kumar M and Tamizhselvi R: Protective effect of diallyl disulfide against cerulein-induced acute pancreatitis and associated lung injury in mice. Int Immunopharmacol. 80(106136)2020.PubMed/NCBI View Article : Google Scholar | |
Marimuthu MK, Moorthy A and Ramasamy T: Diallyl disulfide attenuates STAT3 and NF-κB pathway through PPAR-γ activation in cerulein-induced acute pancreatitis and associated lung injury in mice. Inflammation. 45:45–58. 2022.PubMed/NCBI View Article : Google Scholar | |
Orján EM, Kormányos ES, Fűr GM, Dombi A, Bálint ER, Balla Z, Balog BA, Dágó A, Totonji A, Bátai ZI, et al: The anti-inflammatory effect of dimethyl trisulfide in experimental acute pancreatitis. Sci Rep. 13(16813)2023.PubMed/NCBI View Article : Google Scholar | |
Lunova M, Zizer E, Kucukoglu O, Schwarz C, Dillmann WH, Wagner M and Strnad P: Hsp72 overexpression accelerates the recovery from caerulein-induced pancreatitis. PLoS One. 7(e39972)2012.PubMed/NCBI View Article : Google Scholar | |
Hamada S, Masamune A and Shimosegawa T: Novel therapeutic strategies targeting tumor-stromal interactions in pancreatic cancer. Front Physiol. 4(331)2013.PubMed/NCBI View Article : Google Scholar | |
Saiki Y, Hirota S and Horii A: Attempts to remodel the pathways of gemcitabine metabolism: Recent approaches to overcoming tumours with acquired chemoresistance. Cancer drug Resist. 3:819–831. 2020.PubMed/NCBI View Article : Google Scholar | |
Patel M, Singh P, Gandupalli L and Gupta R: Identification and evaluation of survival-associated common chemoresistant genes in cancer. Biomed Biotechnol Res J. 8:320–327. 2024. | |
Ozalp Unal D and Sel T: Investigation of antiproliferative effects of combinations of white and black garlic extracts with 5-fluorouracil (5-FU) on caco-2 colorectal adenocarcinoma cells. Mol Nutr Food Res. 68(e2300820)2024.PubMed/NCBI View Article : Google Scholar | |
Perez-Ortiz JM, Galan-Moya EM, de la Cruz-Morcillo MA, Rodriguez JF, Gracia I, Garcia MT and Redondo-Calvo FJ: Cost effective use of a thiosulfinate-enriched Allium sativum extract in combination with chemotherapy in colon cancer. Int J Mol Sci. 21(2766)2020.PubMed/NCBI View Article : Google Scholar | |
Horie T, Awazu S, Itakura Y and Fuwa T: Alleviation by garlic of antitumor drug-induced damage to the intestine. J Nutr. 131 (3s):1071S–1074S. 2001.PubMed/NCBI View Article : Google Scholar | |
Petrovic V, Nepal A, Olaisen C, Bachke S, Hira J, Søgaard CK, Røst LM, Misund K, Andreassen T, Melø TM, et al: Anti-cancer potential of homemade fresh garlic extract is related to increased endoplasmic reticulum stress. Nutrients. 10(450)2018.PubMed/NCBI View Article : Google Scholar | |
Zou X, Liang J, Sun J, Hu X, Lei L, Wu D and Liu L: Allicin sensitizes hepatocellular cancer cells to anti-tumor activity of 5-fluorouracil through ROS-mediated mitochondrial pathway. J Pharmacol Sci. 131:233–240. 2016.PubMed/NCBI View Article : Google Scholar | |
Khakbaz P, Panahizadeh R, Vatankhah MA and Najafzadeh N: Allicin reduces 5-fluorouracil-resistance in gastric cancer cells through modulating MDR1, DKK1, and WNT5A expression. Drug Res (Stuttg). 71:448–454. 2021.PubMed/NCBI View Article : Google Scholar | |
Țigu AB, Toma VA, Moț AC, Jurj A, Moldovan CS, Fischer-Fodor E, Berindan-Neagoe I and Pârvu M: The synergistic antitumor effect of 5-fluorouracil combined with allicin against lung and colorectal carcinoma cells. Molecules. 25(1947)2020.PubMed/NCBI View Article : Google Scholar | |
Gao X, Xu C, Santhanam RK, Zhang Y and Zhao Q: Allicin: A natural weapon against Taxol resistance in non-small cell lung cancer through cathepsin B inhibition and lysosomal-autophagy disruption. Food Front. 1–14. 2024. | |
Su J, Xia H, He H, Tang H, Zhou J, Xun Y, Liu F, Su B and Su Q: Diallyl disulfide antagonizes DJ-1 mediated proliferation, epithelial-mesenchymal transition, and chemoresistance in gastric cancer cells. Environ Toxicol. 39:4105–4119. 2024.PubMed/NCBI View Article : Google Scholar | |
Malla R, Marni R, Chakraborty A and Kamal MA: Diallyl disulfide and diallyl trisulfide in garlic as novel therapeutic agents to overcome drug resistance in breast cancer. J Pharm Anal. 12:221–231. 2022.PubMed/NCBI View Article : Google Scholar | |
Hassan HT: Ajoene (natural garlic compound): A new anti-leukaemia agent for AML therapy. Leuk Res. 28:667–671. 2004.PubMed/NCBI View Article : Google Scholar | |
Raisuddin S, Ahmad S, Fatima M and Dabeer S: Toxicity of anticancer drugs and its prevention with special reference to role of garlic constituents. Ann Phytomed. 7:13–26. 2018. | |
Zhang QY, Wang FX, Jia KK and Kong LD: Natural product interventions for chemotherapy and radiotherapy-induced side effects. Front Pharmacol. 9(1253)2018.PubMed/NCBI View Article : Google Scholar | |
Geller LT, Barzily-Rokni M, Danino T, Jonas OH, Shental N, Nejman D, Gavert N, Zwang Y, Cooper ZA, Shee K, et al: Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science. 357:1156–1160. 2017.PubMed/NCBI View Article : Google Scholar | |
Riquelme E, Zhang Y, Zhang L, Montiel M, Zoltan M, Dong W, Quesada P, Sahin I, Chandra V, San Lucas A, et al: Tumor microbiome diversity and composition influence pancreatic cancer outcomes. Cell. 178:795–806.e12. 2019.PubMed/NCBI View Article : Google Scholar | |
Del Castillo E, Meier R, Chung M, Koestler DC, Chen T, Paster BJ, Charpentier KP, Kelsey KT, Izard J and Michaud DS: The microbiomes of pancreatic and duodenum tissue overlap and are highly subject specific but differ between pancreatic cancer and noncancer subjects. Cancer Epidemiol Biomarkers Prev. 28:370–383. 2019.PubMed/NCBI View Article : Google Scholar | |
Nagata N, Nishijima S, Kojima Y, Hisada Y, Imbe K, Miyoshi-Akiyama T, Suda W, Kimura M, Aoki R, Sekine K, et al: Metagenomic identification of microbial signatures predicting pancreatic cancer from a multinational study. Gastroenterology. 163:222–238. 2022.PubMed/NCBI View Article : Google Scholar | |
Pushalkar S, Hundeyin M, Daley D, Zambirinis CP, Kurz E, Mishra A, Mohan N, Aykut B, Usyk M, Torres LE, et al: The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression. Cancer Discov. 8:403–416. 2018.PubMed/NCBI View Article : Google Scholar | |
Maisonneuve P, Amar S and Lowenfels AB: Periodontal disease, edentulism, and pancreatic cancer: A meta-analysis. Ann Oncol. 28:985–995. 2017.PubMed/NCBI View Article : Google Scholar | |
Kawasaki H and Amano H: Anti-inflammatory role of microRNA-429 in human gingival epithelial cells-inhibition of IL-8 production through direct binding to IKKβ mRNA. Mol Med Rep. 24(581)2021.PubMed/NCBI View Article : Google Scholar | |
Michaud DS, Izard J, Wilhelm-Benartzi CS, You DH, Grote VA, Tjønneland A, Dahm CC, Overvad K, Jenab M, Fedirko V, et al: Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study. Gut. 62:1764–1770. 2013.PubMed/NCBI View Article : Google Scholar | |
Fan X, Alekseyenko AV, Wu J, Peters BA, Jacobs EJ, Gapstur SM, Purdue MP, Abnet CC, Stolzenberg-Solomon R, Miller G, et al: Human oral microbiome and prospective risk for pancreatic cancer: A population-based nested case-control study. Gut. 67:120–127. 2018.PubMed/NCBI View Article : Google Scholar | |
Mitsuhashi K, Nosho K, Sukawa Y, Matsunaga Y, Ito M, Kurihara H, Kanno S, Igarashi H, Naito T, Adachi Y, et al: Association of Fusobacterium species in pancreatic cancer tissues with molecular features and prognosis. Oncotarget. 6:7209–7220. 2015.PubMed/NCBI View Article : Google Scholar | |
Gnanasekaran J, Gallimidi AB, Saba E, Pandi K, Berchoer LE, Hermano E, Angabo S, Makkawi H, Khashan A, Daoud A, et al: Intracellular Porphyromonas gingivalis promotes the tumorigenic behavior of pancreatic carcinoma cells. Cancers (Basel). 12(2331)2020.PubMed/NCBI View Article : Google Scholar | |
Shams-Ghahfarokhi M, Shokoohamiri MR, Amirrajab N, Moghadasi B, Ghajari A, Zeini F, Sadeghi G and Razzaghi-Abyaneh M: In vitro antifungal activities of Allium cepa, Allium sativum and ketoconazole against some pathogenic yeasts and dermatophytes. Fitoterapia. 77:321–323. 2006.PubMed/NCBI View Article : Google Scholar | |
Nakamoto M, Kunimura K, Suzuki J and Kodera Y: Antimicrobial properties of hydrophobic compounds in garlic: Allicin, vinyldithiin, ajoene and diallyl polysulfides. Exp Ther Med. 19:1550–1553. 2020.PubMed/NCBI View Article : Google Scholar | |
Ohta R, Yamada N, Kaneko H, Ishikawa K, Fukuda H, Fujino T and Suzuki A: In vitro inhibition of the growth of Helicobacter pylori by oil-macerated garlic constituents. Antimicrob Agents Chemother. 43:1811–1812. 1999.PubMed/NCBI View Article : Google Scholar | |
Cellini L, Di Campli E, Masulli M, Di Bartolomeo S and Allocati N: Inhibition of Helicobacter pylori by garlic extract (Allium sativum). FEMS Immunol Med Microbiol. 13:273–277. 1996.PubMed/NCBI View Article : Google Scholar | |
O'Gara EA, Hill DJ and Maslin DJ: Activities of garlic oil, garlic powder, and their diallyl constituents against Helicobacter pylori. Appl Environ Microbiol. 66:2269–2273. 2000.PubMed/NCBI View Article : Google Scholar | |
Iimuro M, Shibata H, Kawamori T, Matsumoto T, Arakawa T, Sugimura T and Wakabayashi K: Suppressive effects of garlic extract on Helicobacter pylori-induced gastritis in Mongolian gerbils. Cancer Lett. 187:61–68. 2002.PubMed/NCBI View Article : Google Scholar | |
Müller A, Eller J, Albrecht F, Prochnow P, Kuhlmann K, Bandow JE, Slusarenko AJ and Leichert LIO: Allicin induces thiol stress in bacteria through S-allylmercapto modification of protein cysteines. J Biol Chem. 291:11477–11490. 2016.PubMed/NCBI View Article : Google Scholar | |
Petropoulos S, Fernandes Â, Barros L, Ciric A, Sokovic M and Ferreira ICFR: Antimicrobial and antioxidant properties of various Greek garlic genotypes. Food Chem. 245:7–12. 2018.PubMed/NCBI View Article : Google Scholar | |
Fujisawa H, Watanabe K, Suma K, Origuchi K, Matsufuji H, Seki T and Ariga T: Antibacterial potential of garlic-derived allicin and its cancellation by sulfhydryl compounds. Biosci Biotechnol Biochem. 73:1948–1955. 2009.PubMed/NCBI View Article : Google Scholar | |
Bachrach G, Jamil A, Naor R, Tal G, Ludmer Z and Steinberg D: Garlic allicin as a potential agent for controlling oral pathogens. J Med Food. 14:1338–1343. 2011.PubMed/NCBI View Article : Google Scholar | |
Bakri IM and Douglas CWI: Inhibitory effect of garlic extract on oral bacteria. Arch Oral Biol. 50:645–651. 2005.PubMed/NCBI View Article : Google Scholar | |
Shetty S, Thomas B, Shetty V, Bhandary R and Shetty R: An in-vitro evaluation of the efficacy of garlic extract as an antimicrobial agent on periodontal pathogens: A microbiological study. Ayu. 34:445–451. 2013.PubMed/NCBI View Article : Google Scholar | |
Velliyagounder K, Ganeshnarayan K, Velusamy SK and Fine DH: In vitro efficacy of diallyl sulfides against the periodontopathogen Aggregatibacter actinomycetemcomitans. Antimicrob Agents Chemother. 56:2397–2407. 2012.PubMed/NCBI View Article : Google Scholar | |
Aykut B, Pushalkar S, Chen R, Li Q, Abengozar R, Kim JI, Shadaloey SA, Wu D, Preiss P, Verma N, et al: The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL. Nature. 574264–267. 2019.PubMed/NCBI View Article : Google Scholar | |
Okuno K, Tokunaga M, Von Hoff D, Kinugasa Y and Goel A: PDAC Biomarker Working Group. Intratumoral Malassezia globosa levels predict survival and therapeutic response to adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma. Gastroenterology. 165:502–504.e2. 2023.PubMed/NCBI View Article : Google Scholar | |
Narunsky-Haziza L, Sepich-Poore GD, Livyatan I, Asraf O, Martino C, Nejman D, Gavert N, Stajich JE, Amit G, González A, et al: Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions. Cell. 185:3789–3806.e17. 2022.PubMed/NCBI View Article : Google Scholar | |
Alam A, Levanduski E, Denz P, Villavicencio HS, Bhatta M, Alhorebi L, Zhang Y, Gomez EC, Morreale B, Senchanthisai S, et al: Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer. Cancer Cell. 40:153–167.e11. 2022.PubMed/NCBI View Article : Google Scholar | |
Brayer KJ, Hanson JA, Cingam S, Martinez C, Ness SA and Rabinowitz I: The inflammatory response of human pancreatic cancer samples compared to normal controls. PLoS One. 18(e0284232)2023.PubMed/NCBI View Article : Google Scholar | |
Kunovsky L, Dite P, Jabandziev P, Dolina J, Vaculova J, Blaho M, Bojkova M, Dvorackova J, Uvirova M, Kala Z and Trna J: Helicobacter pylori infection and other bacteria in pancreatic cancer and autoimmune pancreatitis. World J Gastrointest Oncol. 13:835–844. 2021.PubMed/NCBI View Article : Google Scholar | |
Nilsson HO, Stenram U, Ihse I and Wadstrom T: Helicobacter species ribosomal DNA in the pancreas, stomach and duodenum of pancreatic cancer patients. World J Gastroenterol. 12:3038–3043. 2006.PubMed/NCBI View Article : Google Scholar | |
Lindén SK, Wickström C, Lindell G, Gilshenan K and Carlstedt I: Four modes of adhesion are used during Helicobacter pylori binding to human mucins in the oral and gastric niches. Helicobacter. 13:81–93. 2008.PubMed/NCBI View Article : Google Scholar | |
Umeda M, Kobayashi H, Takeuchi Y, Hayashi J, Morotome-Hayashi Y, Yano K, Aoki A, Ohkusa T and Ishikawa I: High prevalence of Helicobacter pylori detected by PCR in the oral cavities of periodontitis patients. J Periodontol. 74:129–134. 2003.PubMed/NCBI View Article : Google Scholar | |
Wei X, Zhao HQ, Ma C, Zhang AB, Feng H, Zhang D and Liu C: The association between chronic periodontitis and oral Helicobacter pylori: A meta-analysis. PLoS One. 14(e0225247)2019.PubMed/NCBI View Article : Google Scholar | |
Hirabayashi M, Inoue M, Sawada N, Saito E, Abe SK, Hidaka A, Iwasaki M, Yamaji T, Shimazu T and Tsugane S: Helicobacter pylori infection, atrophic gastritis, and risk of pancreatic cancer: A population-based cohort study in a large Japanese population: The JPHC study. Sci Rep. 9(6099)2019.PubMed/NCBI View Article : Google Scholar | |
Stolzenberg-solomon RZ, Blaser MJ, Limburg PJ, Perez-Perez G, Taylor RP, Virtamo J and Albanes D: Helicobacter pylori seropositivity as a risk factor for pancreatic cancer. J Natl Cancer Inst. 93:937–941. 2001.PubMed/NCBI View Article : Google Scholar | |
Trikudanathan G, Philip A, Dasanu CA and Baker WL: Association between Helicobacter pylori infection and pancreatic cancer. A cumulative meta-analysis. JOP. 12:26–31. 2011.PubMed/NCBI | |
Risch HA: Pancreatic cancer: Helicobacter pylori colonization, N-nitrosamine exposures, and ABO blood group. Mol Carcinog. 51:109–118. 2012.PubMed/NCBI View Article : Google Scholar |